2.Shanafelt TD, Wang XV, Kay NE, et al: Ibrutinib-rituximab or chemoimmunotherapy for chronic lymphocytic leukemia.N Engl J Med 381:432–443, 2019.doi: 10.1056/NEJMoa1817073 3.Sharman JP, Egyed M, Jurczak W, et al: Acalabrutinib with or without obinutuzumab versus chl...